
FAQs about Nirsevimab — the new respiratory syncytial virus (RSV) vaccine
This year, we are very excited to have a new medicine that will help infants and young children stay safer from RSV.

This year, we are very excited to have a new medicine that will help infants and young children stay safer from RSV.

The Centers for Disease Control and Prevention, the American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine all recommend pregnant people get vaccinated against COVID-19.

Respiratory syncytial virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms.

Weaning a young baby can be hard. Ideally, a bottle should be introduced by someone other than the mother at around 1 month of age.

Second to the common cold, lice is the most contagious infectious disease a child can get. Here’s how to treat it.